Annovis Bio ANVS
NYSE ANVS
$1.00 +0.00 (+0.44%)
As of: Oct 22, 2026 · 3:59 PM EDT

Annovis Bio (ANVS) Price to Sales (2020 - 2024)

Updated

Analysis

Annovis Bio (ANVS) Price to Sales (2020 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Annovis Bio 37.11 Mn -30.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 238.63
Mar 31, 2024 273.26
Dec 31, 2023 294.54
Sep 30, 2023 126.53
Jun 30, 2023 221.22
Mar 31, 2023 320.07
Dec 31, 2022 600.08
Sep 30, 2022 981.03
Jun 30, 2022 1,388.47
Mar 31, 2022 3,324.13
Dec 31, 2021 10,679.27
Sep 30, 2021 31,760.08
Jun 30, 2021 53,083.56
Mar 31, 2021 5,268.69
Dec 31, 2020 1,100.32
Sep 30, 2020 954.09
Jun 30, 2020 2,527.91
API Access

Annovis Bio Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=ANVS&period=max&api_key=YOUR_API_KEY